These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21476105)

  • 1. Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death.
    Roses RE; Arun BK; Lari SA; Mittendorf EA; Lucci A; Hunt KK; Kuerer HM
    Ann Surg Oncol; 2011 Oct; 18(10):2873-8. PubMed ID: 21476105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCIS treated with excision alone using the National Comprehensive Cancer Network (NCCN) guidelines.
    Wehner P; Lagios MD; Silverstein MJ
    Ann Surg Oncol; 2013 Oct; 20(10):3175-9. PubMed ID: 23975306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.
    Mamtani A; Nakhlis F; Downs-Canner S; Zabor EC; Morrow M; King TA; Van Zee KJ
    Ann Surg Oncol; 2019 Dec; 26(13):4264-4271. PubMed ID: 31440931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.
    Vicini F; Shah C; Ben Wilkinson J; Keisch M; Beitsch P; Lyden M
    Ann Surg Oncol; 2013 Apr; 20(4):1275-81. PubMed ID: 23054123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer?
    Choi DX; Eaton AA; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2013 Apr; 20(4):1302-10. PubMed ID: 23161115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involved margins after lumpectomy for breast cancer: Always to be re-excised?
    Sorrentino L; Agozzino M; Albasini S; Bossi D; Mazzucchelli S; Vanna R; Papadopoulou O; Villani L; Corsi F
    Surg Oncol; 2019 Sep; 30():141-146. PubMed ID: 31500779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index.
    Kelley L; Silverstein M; Guerra L
    Ann Surg Oncol; 2011 Feb; 18(2):459-62. PubMed ID: 20859695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
    Sanders ME; Schuyler PA; Dupont WD; Page DL
    Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology, treatment, and outcome in very young and older women with DCIS.
    Alvarado R; Lari SA; Roses RE; Smith BD; Yang W; Mittendorf EA; Arun BK; Lucci A; Babiera GV; Wagner JL; Caudle AS; Meric-Bernstam F; Hwang RF; Bedrosian I; Hunt KK; Kuerer HM
    Ann Surg Oncol; 2012 Nov; 19(12):3777-84. PubMed ID: 22622473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.
    Lee LA; Silverstein MJ; Chung CT; Macdonald H; Sanghavi P; Epstein M; Holmes DR; Silberman H; Ye W; Lagios MD
    Am J Surg; 2006 Oct; 192(4):416-9. PubMed ID: 16978940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregional recurrence after mastectomy with immediate transverse rectus abdominis myocutaneous (TRAM) flap reconstruction.
    Patterson SG; Teller P; Iyengar R; Carlson GW; Gabram-Mendola SG; Losken A; Styblo T; Torres M; Wood WC; Perez SD; Mosunjac M; Rizzo M
    Ann Surg Oncol; 2012 Aug; 19(8):2679-84. PubMed ID: 22476750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation.
    Pilewskie M; Olcese C; Eaton A; Patil S; Morris E; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2014 May; 21(5):1552-60. PubMed ID: 24385207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy.
    Weksberg DC; Allen PK; Hoffman KE; Litton JK; Strom EA; Shah RR; Kuerer HM; Hunt KK; Buchholz TA; Mittendorf EA
    Ann Surg Oncol; 2013 Oct; 20(11):3430-7. PubMed ID: 23720073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
    Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
    Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?
    Fitzsullivan E; Lari SA; Smith B; Caudle AS; Krishnamurthy S; Lucci A; Mittendorf EA; Babiera GV; Black DM; Wagner JL; Bedrosian I; Woodward W; Gainer SM; Hwang R; Meric-Bernstam F; Hunt KK; Kuerer HM
    Ann Surg Oncol; 2013 Dec; 20(13):4103-12. PubMed ID: 23975313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
    Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
    Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal carcinoma-in-situ: long-term results of breast-conserving therapy.
    Mirza NQ; Vlastos G; Meric F; Sahin AA; Singletary SE; Newman LA; Kuerer HM; Ames FC; Ross MI; Feig BW; Pollock RE; Buchholz TA; McNeese MD; Strom EA; Hortobagyi GN; Hunt KK
    Ann Surg Oncol; 2000 Oct; 7(9):656-64. PubMed ID: 11034242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients.
    Tunon-de-Lara C; André G; Macgrogan G; Dilhuydy JM; Bussières JE; Debled M; Mauriac L; Brouste V; de Mascarel I; Avril A
    Ann Surg Oncol; 2011 May; 18(5):1372-9. PubMed ID: 21108045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.